JP Morgan Chase’s United Therapeutics UTHR Stock Holding History

JP Morgan Chase’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.5M	Buy	145,300 +144,900	+36,225%	+$72.2M	0.01%	1063
2025 Q4	$195K	Sell	400 -5,000	-93%	-$2.33M	﹤0.01%	5558
2025 Q3	$2.26M	Sell	5,400 -87,500	-94%	-$29.4M	﹤0.01%	3995
2025 Q2	$26.7M	Buy	92,900 +79,800	+609%	+$23.8M	﹤0.01%	1741
2025 Q1	$4.04M	Buy	+13,100	New	+$4.49M	﹤0.01%	3341
2024 Q3	–	Sell	-20,000	Closed	-$6.37M	–	7695
2024 Q2	$6.37M	Hold	20,000	–	–	﹤0.01%	2842
2024 Q1	$4.59M	Buy	+20,000	New	+$4.51M	﹤0.01%	3174
2023 Q2	–	Sell	-19,200	Closed	-$4.3M	–	7354
2023 Q1	$4.3M	Buy	+19,200	New	+$4.73M	﹤0.01%	2951
2018 Q2	–	Sell	-30,000	Closed	-$3.37M	–	5708
2018 Q1	$3.37M	Buy	+30,000	New	+$3.81M	﹤0.01%	2895
2015 Q2	–	Sell	-39,300	Closed	-$6.78M	–	4190
2015 Q1	$6.78M	Buy	+39,300	New	+$5.99M	﹤0.01%	2149

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JP Morgan Chase's UTHR Position: Q1 2026 in Review

JP Morgan Chase increased its United Therapeutics (UTHR) stake by 11% in Q1 2026, buying an estimated $14.6M and bringing the position to 291,621 shares worth $172M. The position accounts for 0.01% of the portfolio, ranked #759.

JP Morgan Chase first reported a position in UTHR in Q2 2013 and has held it in 52 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

JP Morgan Chase held 291,621 shares of United Therapeutics worth $172M as of Q1 2026.
JP Morgan Chase bought 29,406 United Therapeutics shares in Q1 2026, an estimated $14.6M.
United Therapeutics made up 0.01% of JP Morgan Chase's portfolio in Q1 2026, its #759 holding.
JP Morgan Chase first reported a position in United Therapeutics in Q2 2013 and has held it in 52 quarters since.
850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.